News Photocure ASA

Stocks

PHO

NO0010000045

Pharmaceuticals

Market Closed - Oslo Bors 11:45:00 2026-10-28 EDT			5-day change	1st Jan Change
47.50 ^NOK	-5.00%		-5.94%	-33.47%

04:19pm	Photocure ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
03:36pm	Photocure ASA, Q3 2026 Earnings Call, Oct 28, 2026

All News

Mentions Relevance

04:19pm	Photocure ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
03:36pm	Photocure ASA, Q3 2026 Earnings Call, Oct 28, 2026
10-27	ABG Sundal Collier cuts price target for Photocure to 70 Norwegian kroner (75), reiterates buy - BN	FW
10-23	Photocure Names New CFO	MT
10-22	Photocure ASA Appoints Dennis Camporeale as Chief Financial Officer, Effective on October 26, 2026	CI
10-09	Photocure : New publication modelling Bladder Cancer Recurrence and Progression Using the Blue Light Cystoscopy with Cysview Registry	PU
10-07	Photocure : Asieris Enters an Exclusive Licensing Agreement with Theramex for CEVIRA	PU
09-16	Photocure : New publication about Modern Predictive Models for Recurrence and Progression in Patients treated with BLC	PU
08-17	Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II	AQ
08-16	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems	MT
08-14	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II	CI
08-14	Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II	AQ
08-11	Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.	AQ
08-11	Photocure ASA Publishes Healthcare Resource Utilization And Costs Study For Blue Light Versus White Light Cystoscopy In Non?Muscle-Invasive Bladder Cancer	CI
08-07	Photocure ASA: Notification of primary insider transactions	AQ
08-07	Photocure ASA - Share option grant to members of the board of directors	AQ
08-04	Photocure Faces $6.6 Million Counterclaim in Asieris Arbitration	MT
08-04	Photocure ASA: Asieris counterclaim on milestone payment arbitration	AQ
07-29	Photocure ASA - Share option grant	AQ
07-29	Photocure ASA, Q2 2026 Earnings Call, Jul 29, 2026
07-29	Photocure ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Photocure ASA: Results for the second quarter of 2026	AQ
07-23	Photocure : initiates arbitration in partial milestone payment case with Asieris Pharmaceuticals	PU
07-22	Photocure ASA: Invitation to presentation of second quarter 2026 financial results	AQ
07-14	Photocure ASA - Share option grant	AQ